Strandberg’s appointment becomes effective April 24, 2023. She joins Philips’ executive committee, reporting to CEO Roy Jakobs. As of April 1, 2023, Philips intends for its connected care business to comprise monitoring, sleep and respiratory care and enterprise informatics.
Her role could include involvement with the ongoing Philips Respironics recall. Here’s how that recall unfolded. She succeeds Dan Leonard, who took on the role on an interim basis when Jakobs became CEO in October 2022.
Strandberg joins Philips from Pear Therapeutics. At Pear, she served as chief commercial officer, leading the team building, launching and growing Pear’s prescription digital therapeutics.
Before Pear, Strandberg led a healthcare business consulting firm. Prior to that, she led Medtronic’s global health informatics and monitoring business. Strandberg also served as global marketing leader for the patient monitoring business within Covidien’s respiratory & monitoring group. The medtech veteran began her career across a number of roles at 3M.
“On behalf of Philips’ executive committee, I am delighted to announce that Julia Strandberg will join Philips as our new chief business leader of the connected care businesses and member of the executive committee,” Jakobs said. “Julia brings deep, multi-disciplinary expertise, including in informatics and monitoring, to Philips. Passionate about improving the healthcare experience for patients and providers across care settings, Julia understands how to deliver in the global healthcare ecosystem and adds extensive experience in developing and commercializing medical technologies.”